These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9305674)

  • 21. Antiviral therapy for chronic hepatitis C viral infection.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():3-7. PubMed ID: 8720286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of hepatitis C: overview.
    Lindsay KL
    Hepatology; 1997 Sep; 26(3 Suppl 1):71S-77S. PubMed ID: 9305668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clearance of hepatitis C viral RNA in cirrhotic patients with antiviral therapy.
    Ono SK; da Silva LC; Carrilho FJ; da Fonseca LE; Mendes LC; Madruga CL; Farias Ade Q; Laudanna AA
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(5):180-3. PubMed ID: 9216095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral therapy of hepatitis C.
    Schalm SW; Brouwer JT
    Scand J Gastroenterol Suppl; 1997; 223():46-9. PubMed ID: 9200306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moving towards the optimal treatment of chronic hepatitis C.
    Cammà C; Giunta M; Almasio P; Di Marco V; Craxì A
    Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):69-74. PubMed ID: 9265583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Disappointing response of chronic C hepatitis to interferon].
    Theodor E; Regev A
    Harefuah; 1997 Mar; 132(6):402-3, 447. PubMed ID: 9153855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ribavirin treatment in patients with chronic hepatitis C refractory to interferon-alpha].
    Acero D; Adrados M; González-Huix F; Figa M
    Gastroenterol Hepatol; 1996 May; 19(5):243-6. PubMed ID: 8752565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of hepatitis C.
    Fried MW; Hoofnagle JH
    Semin Liver Dis; 1995 Feb; 15(1):82-91. PubMed ID: 7597447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives].
    Marcellin P; Pouteau M; Martinot M; Boyer N; Castelnau C; Benhamou JP; Erlinger S
    Gastroenterol Clin Biol; 1995 Dec; 19(12):991-1000. PubMed ID: 8729410
    [No Abstract]   [Full Text] [Related]  

  • 30. Ribavirin with or without alpha interferon versus no intervention, placebo or alpha interferon for chronic hepatitis C.
    Kjaergard LL; Krogsgaard K; Gluud C
    Cochrane Database Syst Rev; 2002; (1):CD002234. PubMed ID: 11869633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of chronic hepatitis C with a-interferon: an analysis of the literature.
    Niederau C; Heintges T; Häussinger D
    Hepatogastroenterology; 1996; 43(12):1544-56. PubMed ID: 8975964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients.
    Telfer PT; Garson JA; Whitby K; Grant PR; Yardumian A; Hoffbrand AV; Wonke B
    Br J Haematol; 1997 Sep; 98(4):850-5. PubMed ID: 9326177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus infection.
    Lauer GM; Walker BD
    N Engl J Med; 2001 Jul; 345(1):41-52. PubMed ID: 11439948
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of chronic hepatitis C: impact of combination therapy.
    Davis GL
    Curr Gastroenterol Rep; 1999; 1(1):9-14. PubMed ID: 10980920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of hepatitis C].
    Trepo C; Habersetzer F; Bailly F; Berby F; Pichoud C; Berthillon P; Vitvitski L
    Pathol Biol (Paris); 1995 Oct; 43(8):716-24. PubMed ID: 8745594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials.
    Carithers RL; Emerson SS
    Hepatology; 1997 Sep; 26(3 Suppl 1):83S-88S. PubMed ID: 9305670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of hepatitis C: interferon alfa-n1 trials.
    Farrell GC
    Hepatology; 1997 Sep; 26(3 Suppl 1):96S-100S. PubMed ID: 9305672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of "problematic" hepatitis C patients.
    Colombo M
    Ital J Gastroenterol; 1996 Sep; 28(7):393-5. PubMed ID: 8937942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Half of the patients respond to interferon treatment. Combination therapy is an alternative in chronic hepatitis C].
    Weiland O; Norkrans G; Frydén A; Braconier JH
    Lakartidningen; 1995 May; 92(18):1920-2. PubMed ID: 7746045
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of treatment of hepatitis C with interferon alone or combined with other drugs].
    Serfaty L
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S154-66. PubMed ID: 9161527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.